RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal

Nigro, 1974, Combined therapy for cancer of the anal canal: A preliminary report, Dis Colon Rectum, 17, 354, 10.1007/BF02586980 1996, Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research, Lancet, 348, 1049, 10.1016/S0140-6736(96)03409-5 Bartelink, 1997, J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040 Flam, 1996, Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study, J Clin Oncol, 14, 2527, 10.1200/JCO.1996.14.9.2527 Ajani, 2008, Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial, JAMA, 299, 1914, 10.1001/jama.299.16.1914 Milano, 2005, Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome, Int J Radiat Oncol Biol Phys, 63, 354, 10.1016/j.ijrobp.2005.02.030 Salama, 2007, Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience, J Clin Oncol, 25, 4581, 10.1200/JCO.2007.12.0170 Kachnic, 2012, Dose-painted intensity-modulated radiation therapy for anal cancer: A multi-institutional report of acute toxicity and response to therapy, Int J Radiat Oncol Biol Phys, 82, 153, 10.1016/j.ijrobp.2010.09.030 Tsai, 2006, Dosimetric comparison of dose-painted intensity modulated radiation therapy vs. conventional radiation therapy for anal cancer, J Clin Oncol, 27 Myerson, 2009, Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas, Int J Radiat Oncol Biol Phys, 74, 824, 10.1016/j.ijrobp.2008.08.070 Simon, 1989, Optimal two-stage designs for phase II clinical trials, Control Clin Trials, 10, 1, 10.1016/0197-2456(89)90015-9 2009 Mell, 2008, Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 70, 1431, 10.1016/j.ijrobp.2007.08.074 John, 1996, Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08, Cancer J Sci Am, 2, 205 Cannon, 2008, Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer, Int J Radiat Oncol Biol Phys, 70, 660, 10.1016/j.ijrobp.2007.09.018